Purdue Pharma deal has families deflated, angry but hopeful

For those who lost loved ones in the opioid crisis, making sure the family behind OxyContin maker Purdue Pharma paid a price was never just about money. What many wanted was a chance to confront the Sackler family face to face, to make them feel their pain.

While some may get that chance — at least by video — under a tentative settlement reached Thursday that also would force the Sacklers to pay out billions, the families still are coming away feeling empty, conflicted and angry yet again. There's a bit of hope mixed in, too.

Nothing, though, will bring back any of the lives lost or hold the Sacklers fully accountable, in their eyes.

“I’d like to see the Sacklers bleed all they can, but the bigger picture for me is what they’re doing to clean up the mess,” said Vicki Meyer Bishop of Clarksburg, Maryland, who lost her 45-year-old son, Brian Meyer, in 2017. “We’re all so very worried about the next generation and the next child who will be lost.”

The Sacklers, whose wealth has been estimated in court filings at over $10 billion, will get to hang on to a chunk of their vast fortune and be protected from current and future civil lawsuits over opioids.

The deal announced Thursday, which must be approved by a federal bankruptcy judge, requires the Sacklers to pay as much as $6 billion, with $750 million for victims and their survivors. Most of the rest will go to state and local governments to fight the crisis. They also must give up ownership of their company, with the new entity's profits going toward fighting opioid addiction through treatment and education programs.

Some of the survivors of the opioid crisis and relatives of those who died will receive payments. But most will get just a few thousand dollars — not even enough to reimburse the cost of a funeral — and many more who have not filed...